8-KShareholder MattersExhibits & Filings

ALNYLAM PHARMACEUTICALS, INC. 8-K Report, Shareholder Vote Results (May 11, 2020)

Filed May 11, 2020For Securities:ALNY

Summary

Alnylam Pharmaceuticals, Inc. (ALNY) filed an 8-K on May 11, 2020, reporting on the results of its 2020 Annual Meeting of Stockholders held on May 6, 2020. The meeting focused on routine corporate governance matters, including the election of directors, approval of stock incentive and employee stock purchase plans, advisory approval of executive compensation, and ratification of independent auditors. All proposed matters received significant stockholder approval, indicating broad support for the company's management and governance practices. Key outcomes include the re-election of three Class I directors and the approval of amendments to the company's stock incentive and employee stock purchase plans. Additionally, stockholders provided advisory approval for executive compensation and ratified the appointment of PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2020. The strong voting results across all proposals suggest a stable and supportive shareholder base for Alnylam's ongoing operations and strategic direction.

Key Highlights

  • 1All three nominated Class I directors were re-elected with substantial 'For' votes, ensuring continuity in board leadership.
  • 2Stockholders overwhelmingly approved amendments to the Company's 2018 Stock Incentive Plan and the 2004 Employee Stock Purchase Plan.
  • 3A non-binding advisory vote on executive compensation received strong approval from stockholders.
  • 4The appointment of PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2020 was ratified with a very high percentage of 'For' votes.
  • 5The meeting's record date was March 9, 2020, with 113,072,381 shares of common stock outstanding.
  • 6Broker non-votes were present in the director elections and plan approvals, indicating some shares were not voted by their beneficial owners.

Frequently Asked Questions

The 2020 Annual Meeting of Stockholders resulted in the re-election of three Class I directors, the approval of amendments to the Company's 2018 Stock Incentive Plan and 2004 Employee Stock Purchase Plan, advisory approval of executive compensation, and the ratification of PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2020. All key proposals received strong stockholder support.

The advisory vote on executive compensation received strong approval, with a significant majority of votes cast in favor. This suggests that stockholders were generally satisfied with the compensation of the named executive officers at the time of the meeting.

The three directors re-elected as Class I directors were Michael W. Bonney, John M. Maraganore, Ph.D., and Phillip A. Sharp, Ph.D. They were each elected to serve until the Company's 2023 annual meeting of stockholders.

The ratification of PricewaterhouseCoopers LLP as the independent auditor is a routine but important part of corporate governance. It signifies that the stockholders have confidence in the firm chosen by the Board of Directors to provide an objective audit of the company's financial statements for the upcoming fiscal year.